Resumo
Incidence and impact of activating mutations of the RAS-RAF- MEK-ERK pathway in patients with philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders-unclassified (MDS/MPD-U)
Registro en:
Blood. Washington: Amer Soc Hematology, v. 124, n. 21, p. 1-4, 2014.
0006-4971
WOS:000349243503205
Autor
Santos, Fabio P. S.
Lisboa, Bianca
Datoguia, Tarcila S.
Helman, Ricardo
Pereira, Welbert Oliveira
Puga, Renato D.
Miyagi, Mariana
Mata, Evelyn H. A. da
Santucci, Rodrigo
Perini, Guilherme F.
Souto, Eizabeth Xisto
Kassab, Carolina
Padua, Leandro
Bollman, Patricia W.
Higashi, Marcia
Soares, Rodolfo
Fadel, Adriana Valente [UNESP]
Musacchio, Juliane
Schriefer, Ana Fernandes
Salvino, Marco Aurelio
Cordeiro De Farias, Danielle Leao
Perobelli, Leila Martins
Costa, Erika M. M.
Lima, Marinus M.
Mattos, Vinicius R. P.
Silveira, Paulo A. A.
Bacal, Nydia
Guerra, Joao Carlos
Bezerra, Alanna Mara P. S.
Pasqualin, Denise da Cunha
Bello, Isabel C.
Diniz, Michelli Silva
Nakashima, Sandra S.
Velloso, Elvira
Hamerschlak, Nelson
Campregher, Paulo Vidal
Resumen
Hosp Israelita Albert Einstein, Sao Paulo, Brazil HEMOMED, Sao Paulo, Brazil Hosp Brigadeiro, Sao Paulo, Brazil Ctr Hematol Sao Paulo, Sao Paulo, Brazil Hosp Leforte, Sao Paulo, Brazil Hosp Mario Covas, Santo Andre, Brazil Fundacao Hosp Amaral Carvalho, Jau, Brazil Univ Fed Rio Grande do Norte, Nucleo Hematol Hemoterapia, BR-59072970 Natal, RN, Brazil UNESP, Botucatu, SP, Brazil Clin Oncol Integrada, Rio De Janeiro, Brazil Univ Fed Bahia, Salvador, BA, Brazil Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil UNESP, Botucatu, SP, Brazil